tiprankstipranks
LB Pharmaceuticals, Inc. (LBRX)
NASDAQ:LBRX
US Market
LBRX
LB Pharmaceuticals, Inc.
RESEARCH TOOLSreports
Want to see LBRX full AI Analyst Report?

LB Pharmaceuticals, Inc. (LBRX) Financial Statements

43 Followers

LB Pharmaceuticals, Inc. Financial Overview

LB Pharmaceuticals, Inc.'s market cap is currently $850.55M. The company's EPS TTM is $; its P/E ratio is -9.14; LB Pharmaceuticals, Inc. is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ 0.00$ 0.00$ 0.00$ 0.00
Operating Income$ -30.40M$ -64.83M$ -11.38M$ -2.81M
EBITDA$ -30.08M$ -63.01M$ -1.45M$ -12.19M
Net Income$ -25.20M$ -63.10M$ -6.28M$ -14.35M
Balance Sheet
Cash & Short-Term Investments$ 295.21M$ 28.00M$ 43.29M$ 21.40M
Total Assets$ 312.93M$ 33.53M$ 45.66M$ 21.49M
Total Debt$ 3.57M$ 3.70M$ 0.00$ 24.15M
Net Debt$ -246.60M$ -19.27M$ -14.98M$ 2.74M
Total Liabilities$ 11.62M$ 128.09M$ 80.13M$ 50.30M
Stockholders' Equity$ 301.31M$ -94.55M$ -34.47M$ -28.81M
Cash Flow
Free Cash Flow$ -35.26M$ -53.82M$ -12.12M$ -2.73M
Operating Cash Flow$ -35.21M$ -53.05M$ -12.09M$ -2.73M
Investing Cash Flow$ -39.89M$ 23.23M$ -28.01M$ 123.00K
Financing Cash Flow$ 302.56M$ 38.31M$ 33.68M$ 22.96M
Currency in USD

LB Pharmaceuticals, Inc. Earnings and Revenue History

Income Statement >

LB Pharmaceuticals, Inc. Debt to Assets

Balance Sheet >

LB Pharmaceuticals, Inc. Cash Flow

Cash Flow >

LB Pharmaceuticals, Inc. Forecast EPS vs Actual EPS

Earnings >